Clinical trial investigates oral MRGPRX2 antagonist in urticaria
Drug Discovery World
SEPTEMBER 4, 2024
. “As we continue to execute on our clinical development plans for EVO756, we are commencing this Phase II trial in 15 study sites across the United States. Diana Spencer, Senior Digital Content Editor, DDW The post Clinical trial investigates oral MRGPRX2 antagonist in urticaria appeared first on Drug Discovery World (DDW).
Let's personalize your content